t distributions. Additionally, the Probit association parameter estimate was 2.7-46.8-fold less variable than the LG logodds ratio association parameter estimate. Less variability in the association parameter estimate translates to greater power and robustness across the spectrum of minor allele frequencies (MAFs), and these advantages are the most pronounced for rare variants. For instance, in a simulation that generated data from an additive logistic model with an odds ratio of 7.4 for a rare single nucleotide polymorphism with a MAF of 0.005 and a sample size of 2,300, the Probit method had 60% power whereas the LG method had 25% power at the α = 10 -6 level. Consistent with these simulation results, the set of variants identified by the LG method was a subset of those identified by the Probit method in two example analyses. Thus, we suggest the Probit method may be a competitive alternative to the LG method in genetic association studies such as candidate gene, genome-wide, or next-generation sequencing studies for a binary phenotype.
Introduction
For the past 10 years, genome-wide association studies (GWAS) have been an effective and successful method to detect common genetic variations associated with various phenotypes [1] [2] [3] . To date, the majority of phenotypes studied have been binary/categorical, continuous, or survival phenotypes. The standard linear regression model is the main method to analyze continuous phenotypes if the normality assumption holds approximately for its original or transformed scale. The Cox proportional hazard regression model is the key method to analyze the survival outcomes if the proportional hazard assumption holds approximately. The logistic (LG) regression model is widely used to analyze the binary/categorical phenotype in GWAS. Often, a binary phenotype is derived from a continuous variable by splitting the range at some threshold and categorizing individuals above and below that point into 2 separate groups of 'affected' and 'unaffected'. Examples of such designations include obesity defined based on body mass index [4] , hypertension defined based on systolic and/or diastolic blood pressure [5] , and diabetes defined based on hemoglobin A1c level [6] . Moreover, some binary phenotypes may manifest from complicated unobserved or unobservable continuous variables such as expression of an unknown protein in a particular organ that causes the disease. Therefore, the simple LG model may be too naive to adequately reflect the underlying biology, resulting in performance reduction in studies of phenotypes as such.
The Cochran-Armitage trend test (CATT) is a widely used test for the binary phenotype (case-control) which assumes an additive mode of inheritance. CATT is equivalent to the score test for a logistic regression and has high power for additive and multiplicative disease models but much lower power for the recessive disease model [7] [8] [9] [10] . The genotypic association test using Pearson's χ 2 test for a 2 × 3 contingency table is robust for different disease models [11] but generally has lower power than CATT for the additive disease model. MAX3 is another widely used method that is robust for different disease models [12] . MAX3 is the maximum of the absolute values of CATT statistics, assuming the additive, dominant, and recessive disease modes of inheritance. The p value of MAX3 can be estimated by the approximation method implemented in the software [13] because of its complicated asymptotic distribution. Other innovative methods include the entropy-based method which is generally as good as or more powerful than the genotypic association test [11, 14] , and some genetic model selection and genetic model exclusion methods based on Hardy-Weinberg disequilibrium information [15] [16] [17] . Although these methods have some advantages in certain situations, they either cannot adjust for confounding factors such as genetic ancestry, which is commonly adjusted in genetic association studies, as the LG model does, are time consuming when applied to GWAS, or can have lower power than CATT when the underlying disease model is additive or multiplicative [18] , especially for a small sample size.
The set-valued system widely exists in reality. And in some cases, it can degenerate to the well-known threshold model. The corresponding set-valued system identification was first investigated for sensor systems [19] . In contrast to the traditional system identification method, setvalued system identification can estimate the model by set-valued information rather than the precise output. Although set-valued system identification is technically challenging, it has been successfully used in various fields such as sensor networks and telecommunications [20, 21] . If the outcome is a linear function of covariates and the noise follows a normal distribution, then the set-valued system model is referred to as the Probit model, which is a viable choice for genetic association studies. If the noise follows a logistic distribution, then the set-valued system model is referred to as the logistic model, which is widely used in genetic association studies.
While it is widely believed that LG and Probit give very similar statistical analysis results in most applications because the cumulative distribution function of the standard normal distribution is very similar to that of the logistic distribution with a mean of 0 and a scale of 1 [22] , some published research suggests that there may be some GWAS applications in which the two models have very different statistical properties. The LG model can be poorer than the Probit model in terms of goodness of fit in small sample size settings because the logistic distribution has heavier tails than the normal distribution [23] . Also, linear discriminate analysis, which like Probit regression is based on a normal distribution instead of a logistic distribution, has much greater asymptotic efficiency than LG regression [24] . Furthermore, it has been shown that a toxicology study that evaluates a binary response at 3 drug dose levels (-0.79, +0.79, and +2.69 on an arbitrary scale) with most subjects assigned to one of the extreme doses is optimal for differentiating between a LG and Probit regression model in terms of goodness of fit [25] . Furthermore, since changes of ±0.2 in the dose levels have minimal impact on the power to distinguish between the LG and Probit models [24] and the statistical results are invariant to shift and scale transformations of the dose levels, the result holds for transformed dose levels 0, 1, and 2, which is equivalent to the common representation of genotype data as the number of copies of the minor alleles. This result suggests that the LG and Probit models may have very different performance in terms of type I error control and power in the analysis of the association of rare variants with disease status.
In this study, we propose a set-valued (SV) system model, which considers the dichotomization process of continuous phenotypes to model the relationship between the binary outcome and possible genetic or nongenetic explanatory factors in GWAS or next-generation sequencing (NGS) studies. We propose a set-valued system identification approach for the Probit model to estimate the parameter of interest and use a Wald test statistic for testing the null hypothesis ( H 0 ) of no genotype/ binary phenotype association. We performed extensive simulation studies to compare the type I error rate and power of the Probit and LG methods. Finally, we applied both methods to a mini-exome sequencing data set and a candidate gene study.
Materials and Methods

Notation
We assume that there are N 0 cases and N 1 controls in a casecontrol genetic association study (total sample size N = N 0 + N 1 ) and that the genetic polymorphism of interest is diallelic (e.g. a single nucleotide polymorphism; SNP). The 2 alleles at a SNP are denoted as A and a, where A is the minor allele. The 3 genotypes are therefore AA, Aa, and aa. Suppose that observations ( s i , X i , G i ) are available for N individuals, i = 1, 2, …, N , where s i is the casecontrol status of subject i ,
T is the vector of m covariates that we need to adjust for (e.g. demographic or clinical variables), and G i = 0, 1, or 2 is the numerical coding of the 3 genotypes aa, Aa and AA of the SNP for the same individual.
LG Model The LG model [26] commonly used to test the association between a SNP and a binary phenotype with adjustment for some covariates is logit Pr (
where α 0 is an intercept term, θ is the regression coefficient for the
T is a vector of regression coefficients for m covariates. The above equation is equivalent to
Evaluating whether the genetic variant SNP influences the phenotype, adjusting for covariates, corresponds to testing H 0 : θ = 0. The Wald test will be used to test for H 0 in order to be consistent with the Probit method below.
SV Model
Instead of directly modeling the relationship between the genetic variant and the phenotype using the LG model, we propose a new SV system model in which the observation of cases and controls are measured by a set-valued sensor [20, 21] 
where y i is a latent continuous variable that can be dichotomized as case/control, e i is the independent and identically distributed random noise which follows a normal distribution with a mean of 0 and a variance of σ 2 , c is the threshold used to define case/control status, and the observation s i is determined by a threshold c and the latent variable y i . H 0 : θ = 0 corresponds to no genetic effect of the SNP on the phenotype. The parameter θ is to be identified to test for H 0 using the expectation-maximization (EM) algorithm below. Note if function f is a linear function of G and X , but e follows a logistic distribution with a location 0 and a scale of 1, then the SV model becomes the LG model Similarly, it can be seen that
where Φ is the cumulative distribution function for standard normal distribution,
However, an important deviation from the usual Probit model is that here we take a novel system identification approach to estimate all key underlying system parameters θ , γ , and c (see below). We call equation 2 the Probit model but coupled with the new algorithm in the remaining of the paper. The core algorithm of the system identification is the EM algorithm, instead of the traditional Newton-like method which is widely used in the usual Probit regression method. The EM algorithm has outstanding robustness and, without calculating the Hessian-like matrix for every iteration 
Estimation of θ and the Test Statistic
The system parameters in equation 1 can be estimated by maximum likelihood through the EM algorithm [21] . Denote the vector of parameters θ, γ T , and c by Θ, the vector of G , X , and -1 by φ , and the maximum likelihood estimator of Θ by Θ . The iteration process of the EM-based system identification and the Fisher information matrix of Θ at Θ , denoted as i(Θ ), can be obtained as
(for details, see online suppl. section 1) and
where L (Θ) is the likelihood function and F(.) and f(.) are the cumulative distribution function and probability distribution function of a normal distribution with a mean of 0 and a variance of σ 2 , respectively. Testing for no genetic effect of the SNP on the phenotype, i.e. H 0 : θ = 0, can be constructed for the Probit method from the Wald statistic 
Simulations
Data Generation
Simulation studies were performed to compare the relative performance of the Probit method coupled with the proposed EM algorithm and the LG method. In these simulations, given the minor allele frequency (MAF) p A , the genotype frequencies p ( G = g ) were calculated according to the Hardy-Weinberg equilibrium (HWE)
. Two covariates were considered: x 1 was a binary variable that is 1 with a probability of 0.5 and 0 otherwise and x 2 was a continuous variable that follows a standard normal distribution. The genotypes and 2 covariates for a population of 2,000,000 individuals were independently generated from their respective distributions.
The case-control status was determined from the generated genotype and covariate data according to two models, respectively.
( 1) LG model (LGsimu):
2 is the parameter chosen so that the disease prevalence is 0.1 among the subpopulation with
(2) Probit model (PRsimu): first a continuous variable was generated from
where e i follows the standard normal distribution and α 0 = -2.2. Then, the individuals with a large value of y i greater than threshold c = Φ -1 (1 -0.1) + α 0 were declared as cases and the remaining individuals as controls. This model also gives a disease prevalence of 0.1 among the subpopulation with x 1 = x 2 = G = 0.
Then, n cases and n controls were randomly selected from a population of 2,000,000 individuals.
Type I Error Rate Simulations
Eight values for MAFs of SNPs were considered: 0.005, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, and 0.5. The case-control status was determined from the generated genotype and covariate data using the 2 models mentioned above, with θ = 0. To estimate the type I error rate of the Probit and LG method, 10,000,000 replicated data sets were simulated for each case-control study, with a small sample size of 500 cases and 500 controls and a large sample size of 2,000 cases and 2,000 controls, for larger significant levels α = 0.05 or 0.01, and stringent genome-wide levels α = 10 -5 or 10 -6 under H 0 : θ = 0, respectively.
Power Simulations
Three genetic disease models were considered: additive, dominant, and recessive. The case-control status was determined from the generated genotype and covariate data according to the simulation methods given above, with θ varying from 0.3 to 2 at an increment of 0.1. Data sets were generated 10,000 times for each configuration. The LG and Probit methods used for the type I error simulations were applied to each data set, and power was estimated as the proportion of p values < α = 10 -6 . Table 1 shows empirical type I error rates estimated for both the LG and Probit methods. Regardless of significance levels, both methods correctly maintained type I error rates at the given levels but both are conservative if the SNPs are rare and the sample size is small because of large variances of parameter estimates ( table 2 , online suppl. fig. S1 ). Figures 1 and 2 show the power of the LG and Probit methods as a function of effect size ( θ ), for additive and dominant disease models, for n = 500 and 1,000. As expected, the power of both methods increased with the increase in effect size. For a common SNP with a MAF of 0.2 or 0.05, the estimated coefficient of the Probit method . n = 500 ( a , c ). n = 1,000 ( b , d ). ( table 2 ) , which is the case when both models fit well [22] , so it is not surprising that the power of the Probit method was almost identical to or slightly greater than that of the LG method ( fig. 1 , 2 ) , regardless of the effect sizes of the SNP ( θ ) and the genetic disease model. For a rare SNP with a MAF of 0.01 or 0.005, the power of the Probit method was much greater than that of the LG method, regardless of the genetic disease model. The gain in efficiency for the new Probit method was noticeable in detecting rare variants with moderate sample sizes ( fig. 1-3 ) . If the phenotype was simulated using
Simulation Results
Type I Error Rate
Power of the LG and Probit Methods
LGsimu under the additive model, with a total sample size of 1,000, the power of the Probit method was 31%, whereas that of the LG method was 0.05% for detecting a rare SNP with a MAF of 0.01 and an effect size of 2 ( fig. 1 b) . For a total sample size of 2,000, the power of the Probit method was 34%, whereas that of the LG method was only 6% for detecting a rare SNP with a MAF of 0.005 and an effect size of 2 ( fig. 1 d) . If the phenotype was simulated using PRsimu under the additive model, with a total sample size of 1,000, the power of the Probit method was 81%, whereas that of the LG method was 43% for detecting a rare SNP with a MAF of 0.01 and an effect size of 1.8 ( fig. 2 b) . For a total sample size of 2,000, the power of the Probit method was 77%, whereas that of the LG method was only 39% for detecting a rare SNP with a MAF of 0.005 and an effect size of 1.8 ( fig. 2 d) . Figure 3 displays the power of the LG and Probit methods as a function of sample size for the additive and dominant disease models. As expected, the power of both the LG and Probit methods increased with an increase in sample size. For a common SNP with a MAF of 0.2 or 0.05 and an effect size of 0.4 or 0.8, respectively, the power of the Probit method was almost identical to that of the LG 110 method, regardless of the phenotype simulation model, sample size, and disease model. For a rare SNP with a MAF of 0.01 or 0.005 and an effect size of 1.6 or 2, respectively, the power of the Probit method was generally greater than that of the LG method, regardless of the phenotype simulation model and disease model. The power difference became larger with moderate sample sizes. If the phenotype was simulated using LGsimu under the additive model, with a total sample size of 2,100, the power of the Probit method was 80%, whereas that of the LG method was 73% for detecting a rare SNP with a MAF of 0.01 and an effect size of 1.6. For a total sample size of 2,700, the power of the Probit method was 81%, but that of the LG method was only 56% for detecting a rare SNP with a MAF of 0.005 and an effect size of 2 ( fig. 3 a) . If the phenotype was simulated using PRsimu under the additive model, with a total sample size of 1,000, the power of the Probit method was 65%, whereas that of the LG method was 30% for detecting a rare SNP with a MAF of 0.01 and an effect size of 1.6. For a total sample size of 2,000, the power of the Probit method was 83%, whereas that of the LG method was only 48% for detecting a rare SNP with a MAF of 0.005 and an effect size of 2 ( fig. 3 b) .
The relationship between all parameter values and the ratio of the power of the Probit method to that of the LG method was quantified by simulation studies. The relative power for a wide range of parameter setups ( θ ( ≠ 0), n , p A , and PRsimu or LGsimu) was obtained first, and linear regression analysis was then performed using the log-relative power as the outcome variable and the true parameter values as explanatory variables. The estimated mean log-relative power of Probit to LG for testing H 0 : θ = 0 was 2.90-0.85 log 10 ( n ) -2.47 p A + 0.13 θ -0.11 I (PRsimu). This indicates that the magnitude of θ , sample size n , and the MAF of SNP p A play a dominant role in the relative power for testing H 0 : θ = 0.
Next, we study the performance of the Probit method compared to the entropy-based method [11] by simula- 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 . n = 500 ( a , c ). n = 1,000 ( b , d ).
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The tions. Parameter setups were the same as those for figures 1 and 2 , except that we did not include any covariates here and that we used sample sizes of n = 1,000 and 2,000. Figure 4 displays the power difference between the Probit and the entropy-based method for 3 disease models. The power of the Probit method was greater than that of the entropy-based method for the additive and dominant disease models, if the MAFs of the SNP were 0.2, 0.05, and 0.01 ( fig. 4 a, b) . If the sample size was 2,000, then the Probit method outperformed the entropy-based method for a SNP with a MAF of 0.005. The maximum of the absolute values of the power differences between the Probit and the entropy-based method for the additive and dominant models was 0.1. However, for the recessive disease model, the entropy-based method was dominant over the Probit method. The power difference between the Probit and the entropy-based method could be as large as 0.80 ( fig. 4 c) . For SNPs with MAFs 0.01 and 0.005, there is no power difference between the 2 methods for the recessive disease model, because the power of the 2 methods was 0 due to the small sample size ( fig. 4 c) . These results are in fact consistent with the comparisons between the LG and the entropy-based method in the literature [11, 14] .
Variance of the Genetic Association Parameter Estimates
To show how the MAF of a SNP, sample size, genetic disease model, and different distribution of noise affect the parameter estimates of Probit and LG, respectively, and how they affect the ultimate power or type I error rate of both methods, respectively, we have conducted a series of simulations with a small sample size, n = 500, and large sample sizes, n = 2,000, 3,000, 5,000, and 10,000, to investigate the genetic association parameter estimates and variance of genetic association parameter estimates. Table 2 and online supplementary figure S1 show the mean estimates of the genetic effect size association parameter, averaged estimated asymptotic variances, and empirical variances for the LG and Probit methods. Data were generated using the same parameter setup as given in table 1 and figures 1 and 2 , except for the sample sizes. If θ = 0, regardless of the phenotype simulation model, the mean estimates with both the LG and Probit methods were close to 0, but estimates with the Probit method were closer to 0 than those with the LG method ( table 2 , online suppl. fig. S1B ). If θ ≠ 0, the mean estimates with the LG method appeared to be much closer to the true parameter values than those with Probit if the phenotype was generated from the LG model using LGsimu (and vice versa using PRsimu; table 2 , online suppl. fig. S1B ). On average, the parameter estimates by the LG method were 2.11 times greater than those by the Probit method for a small sample size of n = 500, but this factor decreased to 1.83, 1.80, 1.77, and 1.74 for large sample sizes of n = 2,000, 3,000, 5,000, and 10,000, respectively ( table 2 , online suppl. fig. S1A ). As expected, with the increase of sample size, the estimates become more robust and closer to their true parameter values, regardless of the estimation method ( table 2 , online suppl. fig. S1A, B) . Not surprisingly, the more common the SNP and/or the larger the sample size, the smaller was the bias of its estimate.
The averaged estimated asymptotic variance for the parameter estimates appeared to be close to its empirical counterpart for both the LG and Probit methods for the common SNP ( table 2 , online suppl. fig. S1C, D) . Interestingly, for a small sample size, the averaged estimated as- LGsimu n = 1,000 PRsimu n = 1,000 n = 2,000 n = 2,000 b Power difference c Power difference ymptotic variance for the LG method was much larger than its empirical counterpart (mean: 26.9, range: 0.7-470.6), especially for rare SNPs (mean: 90, range: 7.6-470.6), but not for the Probit method (mean: 1.2, range: 0.6-2.9), regardless of the phenotype simulation model ( table 2 , online suppl. fig. S1C, D) . The association parameter estimates for the Probit method were 2.66-46.8-fold less variable than those for the LG method. On average, for a SNP with a MAF of 0.2, the empirical variance obtained by the LG method was 3.48 times (range: 2.67-38) that obtained by the Probit method, which is close to the ratio of the variance of the logistic distribution with a scale of 1, i.e. π 2 /3, to that of the standard normal distribution, i.e. 1. However, this value increased to 4.94 for a small sample size of n = 500 ( table 2 , online suppl. fig.  S1F ). Interestingly, for a SNP with a MAF of 0.005, the empirical variance obtained by the LG method was 24.3 times (range: 2.67-195) that obtained by the Probit method, which is about 7 times larger than that for a SNP with a MAF of 0.2. This value increased to 35.1 for a small sample size of n = 500 ( table 2 , online suppl. fig. S1F ). All of these simulation results obviously demonstrate that Probit can give more robust and much less variable parameter estimates than LG, it is especially dominant for small sample sizes and rare variants, which translate to a higher power of Probit than that of LG.
Application to the Mini-Exome Data of Genetic Analysis Workshop 17
To evaluate the performance of the Probit method coupled with the new proposed algorithm, we analyzed data from the Genetic Analysis Workshop 17 (GAW17) which contained 'mini-exome' sequence genotype data of 24,487 SNPs in 3,205 genomic regions of 697 unrelated individuals provided by the 1000 Genome Project [27] . Three quantitative phenotypes were simulated from the normal distribution. Two quantitative phenotypes and one latent disease liability were influenced by 39 SNPs in 9 genes, 72 SNPs in 13 genes, and 51 SNPs in 15 genes, respectively. The third quantitative phenotype was influenced only by the environments and not by genetic variants. One qualitative phenotype, denoted by Q 4 , was simulated based on the 3 quantitative phenotypes and the latent liability, and the top 30% of the distribution was declared affected. Furthermore, 200 replicate data sets were generated for each phenotype, using fixed genotype data. First, quality control analysis was performed on the SNPs, and SNPs with MAFs <0.00075 or HWE test p values <0.00001 were excluded. The 1st, 10th, 100th, and 200th qualitative traits were used as our outcomes and included age, gender, and smoking status as covariates in both the LG and Probit models.
At a significance level of 0.0001, no SNP was statistically significant for both the LG and the Probit method for the 10th replicate data. Both methods identified the same causal SNP (C13S523) for the 1st and 100th replicate data. The Probit method identified 2 causal SNPs (C13S523 and C13S522) but the LG method only identified the causal SNP C13S522 for the 200th replicate data ( table 3 ) . Neither method identified no-causal SNPs at the significance level of 0.0001. On average, the Probit method identified fewer non-causal SNPs than but the same number of causal SNPs associated with the qualitative phenotype as the LG method at the significance levels of 0.05, 0.01, and 0.001 (online suppl. table S1).
Application to the ARID5B Gene in Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children and has different incidence rates in different racial/ethnic groups [28] . Genetic variants in ARID5B associated with a risk of ALL have been reported recently [29, 30] . We analyzed ARID5B genetic polymorphisms in childhood ALL in two populations of white and Hispanic children [31] . 978 white and 330 Hispanic children enrolled in the Children's Oncology Group clinical trials [32] , 1,046 white controls from the Genetic Association Information Network schizophrenia cohort [33, 34] , and 541 Hispanic controls from HapMap II, the Human Variation Panel, and Mexican participants in the Genetics of Asthma in Latino Americans study [35] were genotyped using Affymetrix SNP Array 6.
After quality control analysis, 49 SNPs within 10 kb upstream or downstream of the gene were included for ( table 4 ) . In Hispanics, both methods identified the same set of SNPs associated with ALL susceptibility ( table 4 ) . At more liberal significance levels of 0.05 and 0.01, both methods identified the same set of SNPs, too (data not shown).
Discussion
With the availability of data from whole-genome sequencing and whole-exome sequencing studies, in which moderate sample sizes are used due to the high cost of sequencing technology [36, 37] , or of data from rare diseases in cancer genomics studies, such as pediatric cancers of retinoblastoma and Ewing's sarcoma [38, 39] , there is an increasing demand for the development of powerful and robust association testing procedures for identifying genetic variations associated with a binary phenotype of interest. In this study, we propose a new SV system model, which is a generalized form of the LG and Probit methods, to reproduce the relationship between a binary phenotype and genetic variants and a novel setvalued system identification approach for the Probit method to identifying the parameters' association of interest. We compared it with the LG model. Simulations and real data applications show that the power gain of the Probit compared to the LG method for binary phenotypes is robust to the distributions of noise: logistic or normal distribution, and various genetic disease models, and that the Probit method generally outperforms the commonly used LG method. Furthermore, we also compared the elapsed time between our new algorithm and the built-in command glmfit (x, y, 'binomial', 'link', 'probit') in Matlab using simulations. We found that, on average, the elapsed time of our new algorithm took 0.06 s (range: 0.003-0.1022) less than glmfit for one SNP. For GWAS and NGS studies, we usually test for approximately 10 6 and 4 × 10 7
SNPs, respectively; the new algorithm will save roughly 17 and 677 h, respectively, compared to glmfit in Matlab [40] . However, we did not find a difference of computing time between our new algorithm and the glm function in R. In addition, the Probit method has greater power than the entropy-based method for the additive and dominant but not for recessive disease models. However, to the best of our knowledge, there is no program available in the entropy-based method to include covariates in genetic association studies. In conclusion, we recommend the use of the Probit method coupled with our new algorithm instead of the LG method, regardless of the distribution of noise, sample size, and effect size of associations between variants and disease of interest, to identify genetic variants, especially rare variants, in genetic association studies. When we estimate the parameters using a system identification method, we suppose that the variance of noise is known as 1, because we are interested in testing genotype-phenotype associations and not in estimating the effect size of association. In real data analysis, the true variance of noise is usually unknown and it may also not be equal to 1, which will definitely affect the power of the LG and Probit methods. By simulations with noise following ), where σ 2 = 3 and σ 2 = 1/3, not surprisingly, as the true variance of the noise is >1, the power of both methods will decrease (and increase when the true variance of the noise is <1). However, as expected, the power of the Probit method is still identical to or greater than that of the LG method (data not shown). Thus, conclusions about the relative performance of the Probit and LG methods in this study are also robust to the t distribution of the underlying noise. In addition, if we are interested in estimating the association effect size of SNPs on the phenotype, the parameter of variance of noise can also be estimated along with other parameters using an expectation-conditional maximization algorithm [21] .
Besides SNP-based analysis, the Probit model coupled with the new algorithm can also be applied to any biologically meaningful mutant and mutant set. It can be applied to a multi-allelic locus and the somatic status of structural variants such as copy number variants, copyneutral regions of loss of heterogeneity, inversions, and translocations. For NGS studies that involve rare variants, due to a lack of power for a single-locus approach, the Probit method can be extended to a multiple locus such as a haplotype-based, gene/set-based, and pathway-based approach for detecting rare variants. Furthermore, the proposed SV model focuses on a binary phenotype with one threshold. However, in real data analyses, especially in the field of pharmacogenomics, the outcome could be multiple ordinal categories such as dosing of drugs, adverse events scored on scales using ordinal values (1) (2) (3) (4) (5) according to the Common Terminology Criteria for Adverse Events developed by the National Cancer Institute, or the effect of treatment on disease (e.g. tumor response in which the change of tumor size is categorized as a complete response, partial response, stable disease, or progressive disease) [39] . The concept of a multiple-inputmultiple-output linear system with quantized outputs [21] can be applied in these cases and hence can provide a comprehensive framework for a wide variety of genetic association studies. Similar to the LG method, the Probit method has also lower power than the entropy-based method if the unknown underlying disease model is recessive. The power of the Probit method can be made robust against the underlying disease models by a computationally intensive approach: as the test statistic, take the maximum of the absolute values of z test statistics assuming the additive, dominant, and recessive disease models in the Probit model. Then an empirical p value can be obtained by a re-sampling method. In the current study, we have only investigated which method, LG or Probit, performs better in terms of association testing, but in the future, we will determine which method performs better in terms of model fitting and prediction.
We have implemented the Probit model coupled with the proposed EM algorithm in an R package and Matlab codes, which are available for free from http://www. stjuderesearch.org/site/depts/biostats/software. The method can be easily applied to any genetic association study for a binary phenotype, no matter the candidate gene, GWAS or NGS studies.
